Purchase Order 75N95023P00236

Award Date 7/1/23
Potential Completion Date 6/30/25
Potential Value $114K
Contracting Federal Agency
National Institute on Drug Abuse
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Madison, WI 53704, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Labcorp Early Development Laboratories Inc., a for-profit organization, for mass balance studies. The contract has a potential value of $416,126.00 and a completion date of December 16, 2020. This contract was not set aside. Labcorp Early Development Laboratories Inc. is a subsidiary of Laboratory...
This is a definitive contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $641,490.62, was awarded to Labcorp Early Development Laboratories Inc., a subsidiary of Laboratory Corporation of America Holdings, a for-profit organization. The contract is for regulatory and support services related to the development of investigational new drugs. It is a firm...
This is a firm fixed-price delivery order contract awarded by the Northeast Area division of a civilian federal agency to Labcorp Early Development Laboratories Inc., a subsidiary of Laboratory Corporation of America Holdings. The $94,239.14 contract is for the provision of laboratory testing and analytical services, including stability testing, potency and safety assays, polyclonal antibody production, pharmacokinetics testing, compositional analysis, and other services to support the work of...
This is a firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency under the National Institutes of Health (NIH), to Labcorp Early Development Laboratories Inc., a for-profit subsidiary of Laboratory Corporation of America Holdings. The contract, valued at $113,830.32, is for the company to perform whole genome DNA methylation profiling and genotyping on 580 DNA samples. The work is to be conducted at the contractor's facility in...
This is a $5,273,743 firm fixed-price definitive contract awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to Labcorp Early Development Laboratories Inc., a subsidiary of Laboratory Corporation of America Holdings. The contract does not have a set-aside designation. Under this contract, Labcorp will provide a range of laboratory testing and analytical services to support the federal government, including stability testing, potency and safety assays for drug...
This federal contract award to Labcorp Early Development Laboratories Inc., a subsidiary of Laboratory Corporation of America Holdings, is a firm fixed-price delivery order contract awarded by the Northeast Area of a civilian federal agency. The contract, which has a ceiling value of $165,447.00, is for a variety of laboratory testing and analytical services, including stability testing, potency and safety assays, polyclonal antibody production, and pharmacokinetics testing for various...
Laboratory Corporation of America (LabCorp) has been awarded a firm fixed price purchase order valued at $20,000 by the Department of Health and Human Services' National Institutes of Health Clinical Center. The order is for laboratory testing services to be performed by LabCorp at its facility located in Greenwood Village, Colorado. No set-aside designation was applied to this procurement. As the prime contractor, LabCorp will provide unspecified testing services to support the NIH Clinical...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $300,054.00 firm fixed price purchase order contract to Laboratory Corporation of America (LabCorp) to provide laboratory testing services. The contract has an end date of April 30, 2021 and was not set aside for any specific business types. LabCorp, a for-profit organization, is the prime contractor and has previously received other federal contract awards, including work as a...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Labcorp Early Development Laboratories Inc., a for-profit contract research organization. The $19,430.00 contract is for canine plasma protein binding services, which involves analyzing the binding of drug compounds to proteins in animal plasma samples. This work supports NIH's mission of advancing...
This is a firm fixed-price delivery order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Laboratory Corporation of America (Labcorp), a leading global life sciences company. The $164,894 contract is for "NEXTGEN SEQUENCING AND OMICS SERVICES" with an ultimate completion date of August 30, 2017. Labcorp, the prime contractor, has a strong track record of providing comprehensive clinical laboratory services to federal agencies, including...

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $114,365 firm fixed price purchase order to Labcorp Early Development Laboratories Inc. to complete the pharmacokinetics portion of the Phase 1 RR-HNK study. Labcorp Early Development Laboratories, a subsidiary of Laboratory Corporation of America Holdings, will perform the work over a two-year period from July 2023 through June 2025 at its facility in Madison, Wisconsin. No set aside designation or subcontractors were indicated. This contract supports the National Institutes of Health's efforts to advance new treatments from research into clinical practice through translational sciences research.

Generated 12/22/23, 10:14 PM